A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance
Point-of-care (POC) nucleic acid detection technologies are poised to aid gold-standard technologies in controlling the COVID-19 pandemic, yet shortcomings in the capability to perform critically needed complex detection-such as multiplexed detection for viral variant surveillance-may limit their wi...
| Other Authors: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mary Ann Liebert Inc
2023
|
| Online Access: | https://hdl.handle.net/1721.1/150365 |